Session Type
Meeting
Search Results for Cirrhosis
Abstract Number: 76
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Patients with cirrhosis and hepatitis C virus (HCV) infection who have achieved sustained virologic response (SVR) currently undergo indefinite imaging every 6-12 months to screen for hepatocellular carcinoma (HCC). Although current research shows there is liver remodeling with regression of fibrosis/cirrhosis after HCV treatment, it is unclear if improvements in the features of cirrhosis […]
Abstract Number: C8
SHM Converge 2022
Background: Esophageal varices with bleeding (EVB) are one of the most common causes of deaths in cirrhotic patients in the United States. Over the course of years, studies have reported an increase in the incidence of EVB and is associated with a high risk for morbidity and mortality. Data is lacking with regards to recent […]
Abstract Number: H9
SHM Converge 2022
Background: Epidemiology of Non-Variceal Upper Gastrointestinal Bleeding (NVUGIB) such as peptic ulcer bleeding, Mallory-Weiss tear, erosive gastritis/duodenitis, oesophagitis/oesophageal ulcer is well known among general population. However, data is lacking about its trend among Cirrhotic population in literature. No large database study is available to compare prevalence, predictors, and outcomes of NVUGIB among Cirrhotic patients. We […]
Abstract Number: 117
SHM Converge 2023
Background: Proton pump inhibitors (PPIs) have been associated with adverse events and increased mortality in patients diagnosed with cirrhosis (1). PPIs are commonly prescribed to patients with cirrhosis who present to the hospital with gastrointestinal bleeds (2). However, guidelines do not suggest routine usage of PPI in patients with cirrhosis without gastroesophageal reflux disease (GERD) […]
Abstract Number: 117
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Spontaneous bacterial peritonitis (SBP) is a life-threatening infection in patients with cirrhosis. Depending on the clinical setting, the prevalence and mortality rates of SBP in cirrhosis range between 1.5-30% and 10-46%, respectively. The purpose of this study was to assess the yearly trend in SBP prevalence, length of stay and mortality among hospitalized cirrhosis […]
Abstract Number: 122
Hospital Medicine 2020, Virtual Competition
Background: Renal dysfunction is a complication in patients with decompensated cirrhosis. Due to the potential morbidity and mortality of these disorders in cirrhotic patients, it is important to ensure accurate clinical measurements of renal function. Standard creatinine-based estimated glomerular filtration rate (eGFR) equations have proven to be inaccurate in cirrhotic patients, as these patients have […]
Abstract Number: 132
SHM Converge 2023
Background: Patients with cirrhosis complicated by ascites are often admitted to the hospital and require abdominal paracentesis for diagnostic evaluation and symptom relief. When large volumes are removed there is a risk for acute kidney injury (AKI) which can contribute to morbidity and mortality. There are no clear guidelines for what constitutes a safe volume […]
Abstract Number: 204
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Paracentesis is associated with decreased mortality in patients with advanced liver disease. The prevalence of paracentesis related complications is not well characterized, but prior studies suggest improved safety outcomes when ultrasound guidance is employed. The Agency for Healthcare Research and Quality utilizes patient safety indicator (PSI) 27 to identify postoperative bleeding complications. Our aim […]
Abstract Number: 209
Hospital Medicine 2020, Virtual Competition
Background: Spontaneous bacterial peritonitis (SBP) is a commonly encountered complication of end stage liver disease that carries a high morbidity and mortality. Risk factors for SBP are defined by the American Association for the Study of Liver Diseases (AASLD) as a prior history of SBP, active gastrointestinal bleeding, and low ascites total protein (< 1.5 […]
Abstract Number: 267
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Patients with refractory ascites often require large volume paracentesis (LVP) on a frequent basis. Most of the studies examining the clinical effects of LVPs, however, have looked only at one-time procedures. In addition, patients with ascites commonly present to the emergency department or require hospital admission for this procedure, leading to high health-care utilization. Our […]